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1. Introduction  
Anaphylaxis is a life-threatening and systemic disorder that involves several organs and 
may lead to death. It is believed to be mostly triggered by release of mediators from 
activated mast cells, basophils and macrophages after allergen exposure. There are two 
major types of anaphylactic mechanisms: classical and alternative anaphylactic pathways. 
Classical anaphylactic pathway is triggered by cross-linking of IgE bound to FcRI, high 
affinity IgE receptors, on mast cell and basophil surfaces to release pre-formed vasoactive 
amines (e.g. histamine), lipid mediators and neutral proteases from secretory granules upon 
allergen exposure. The alternative anaphylactic pathway is an IgE-independent mechanism 
and involves basophils and macrophages. Upon allergen exposure, IgG-immune complexes 
binds to FcRIII, low affinity activating IgG receptor, and subsequent release PAF (platelet 
activating factor), but not histamine as major mediator. The understanding of immune 
mechanisms on triggering anaphylaxis is crucial for understanding how to manipulate the 
immune system to find better therapeutic interventions. 
 Helminth infection and their products have been demonstrated as potential therapeutic 
interventions in inflammatory disorders. Helminths use several imunomodulatory strategies 
to evade and/or modify the host immune response in order to survive in the host, including 
suppression or inactivation of host antigen-specific immune response. The modulation of 
the immune system has been considered beneficial for both host and parasites since it could 
avoid helminth eradication and protect the host from inflammatory responses which may 
damage host’s tissues and organs. Several helminth immunomodulatory molecules and 
strategies have been identified and reported, such as eotaxin metalloproteinase, calreticulin, 
antioxidants and neutrophil inhibitory factor. They interfere with antigen processing and 
presentation, cell proliferation, cause T cell death, decrease IgE responses, reduce B cell 
activation and stimulate regulatory T cells. Therefore, these immunomodulatory factors can 
affect both the inductive and effector immune response, being suitable to modulate the 
inflammatory, allergic and anaphylactic responses. 
Our studies have been focused in the immunossuppressive responses induced by 
roundworms Ascaris suum infection and a protein secreted by these worms named PAS-1 
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(protein from Ascaris suum). We have demonstrated that PAS-1 suppresses LPS-induced 
inflammation due to stimulating the secretion of IL-10 and TGF-. Furthermore, PAS-1 was 
demonstrated suppressing B and T cell responses against OVA. Besides playing a down-
modulatory effect in inflammatory responses induced by unrelated antigens, PAS-1 
suppresses the acute and chronic lung allergic inflammation induced by APAS-3 (allergenic 
protein from Ascaris suum). In OVA/alum lung inflammation model, PAS-1 down-
modulates the lung inflammatory response due CD4+CD25+FoxP3+ cells and CD8+TCR+ 
cells, which secretes IL-10/TGF- and IFN-, respectively. In chronic lung inflammation 
model using OVA/alum or alum/APAS-3, besides inhibiting the inflammation into the 
lungs, PAS-1 also inhibits the airway remodeling by decreasing the activity of 
metaloproteinases and the production of angiogenic factors (IL-13 and VEGF). Taken 
together, these findings demonstrated that PAS-1 inhibits both acute and chronic lung 
inflammation in mouse models.  
The understanding of immune modulatory mechanisms that control anaphylactic responses 
is critical to investigate therapeutic interventions for anaphylactic inflammatory disorders. 
The purpose of this chapter is to discuss the mechanisms triggered by allergic and 
anaphylactic reactions and potential therapeutic strategies using helminth products. 
2. Immune responses triggered by anaphylactic reactions  
2.1 Concept of anaphylaxis 
Anaphylaxis is a systemic and immediate hypersensitivity with multi-organ system 
involvement that can progress potentially to a life-threatening reaction causing thousands 
deaths in the world. The term anaphylaxis was named by Dr Charles Robert Richet, a Nobel 
laureate in Physiology or Medicine in 1913. In 1902, Richet and his colleague Paul Portier 
reported that dogs immunized with non-lethal dose of sea anemone venom display fatal 
reactions to the second injection of the venom even in small doses. Shibasaburo Kitasato and 
Emil von Behring had previously demonstrated that animals immunized with bacterial 
toxins are able to produce anti-toxins (neutralizing antibodies). Since then, this phenomenon 
was named anaphylaxis, which term is derived from the Greek words “a-” (against) and “–
phylaxis” (protection). 
Anaphylaxis can occur following exposure to several allergen sources including food 
allergens, aeroallergens, venoms, drugs and vaccination. The most common symptoms 
include itching, erythema and urticaria after the exposure to allergens. The most severe 
cases of anaphylaxis involve cardiovascular and respiratory system with drop of cardiac 
pressure, bronchoconstriction, laryngeal edema and shock (Brown, 2004). The 
gastrointestinal system may be also involved featuring vomiting, abdominal pain and 
diarrhea. The central nervous system can be affected leading to a felling of impending doom 
and lack of consciousness related to hypotension and hypoxia. Once the anaphylactic 
reactions occur rapidly, an effective treatment (usually epinephrine injection) may avoid the 
occurrence of severe symptoms (Simons et al., 2003). Thus, it is crucial to understand the 
molecular mechanisms involved on anaphylactic reactions for strategically managing the 
risk and preventing recurrence. 
2.2 Types of anaphylactic reactions 
Anaphylaxis occurs due to release of vasoactive and inflammatory mediators from mast 
cells, basophils and macrophages upon allergen exposure. When antigens cross-link FcRI-
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bound IgE or bind to IgGs, which are found as IgG-immune complexes attached to FcRs, 
mainly FcRIII, a signaling cascade is trigger to promote release of mediators which cause 
smooth muscle contraction and increase vascular permeability, leading to laryngeal edema 
(which may cause respiratory difficulty), hypotension, urticaria, abdominal muscular 
contraction, diarrhea (Ewan, 1998). It is reported that anaphylactic reactions in rodent 
models are induced by two different pathways: classical and alternative anaphylactic 
pathways (Figure 1). 
 
 
Fig. 1. Classical and alternative anaphylactic pathways. In the classical anaphylactic 
pathway, cross-linking among IgE-bound FcRI and specific antigen leads to mast cell and 
basophil degranulation and secretion of histamine as major mediator. In the alternative 
anaphylactic pathway, IgG-immune complexes bind to FcRIII on basophil and macrophage 
surfaces, triggering the secretion of PAF as major mediator. Basophils also secrete IL-4 that 
is crucial for IgE class-switching. 
Classical anaphylactic pathway is triggered by cross-linking of antigen and antigen-specific 
IgE bound to FcRI on mast cell and basophil surfaces, which stimulates these cells to 
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degranulate and release histamine, serotonin, lipid mediators (such as leukotrienes) and 
cytokines (such as IL-4, TNF, IL-1, VEGF) (Kumar & Sharma, 2010). Strait et al. (2003) have 
demonstrated that IgE-mediated anaphylaxis depends on IL-4/IL-4R, mast cells, FcRI, 
IgE, histamine and H1 receptor but does not depend on macrophages, serotonin and 
leukotrienes. Alternative anaphylactic pathway is triggered by IgG-immune complexes 
bound to FcRIII on basophils and macrophages, causing release of PAF (Mukai et al., 2009). 
2.3 Cells involved in anaphylactic reactions 
2.3.1 Mast cells 
Mast cells were identified by Paul Ehrlich in 1879 (reviewed in Beaven, 2009) as cells present 
in connective tissues that reacts metachromatically with aniline dyes. He named them 
Mastzellen due the presence of granules that he believed to have a nutritional role on this cell 
type (the word mast denotes fattening in German). Mast cells are generated from bone 
marrow immature cells that migrate to skin and intestine and differentiate into connective 
tissue mast cells and mucosal mast cells, respectively (Arinobu et al., 2005; Galli et al., 2005). 
Stem cell factor (SCF or c-kit ligand) and c-kit play an important role in the growth and 
differentiation of mast cells, which express c-kit constitutively at all stages of differentiaton 
(Hu et al., 2007). They serve as important effector cells of the innate immune system along 
with other cell types (i.e. macrophages, dendritic cells, neutrophils, NK cells).  
In anaphylactic reactions, mast cells are the effector cells in triggering the classical 
anaphylactic pathways. They express constitutively FcRI, high affinity IgE receptor, which 
are usually bound to monomeric IgE upon antigen exposure. This receptor-IgE complex is 
cross-linked with multivalent antigens that consequently stimulate the release of effector 
mediators such as histamine, lipid mediators, and cytokines, which are pre-formed and 
stored in secretory granules of mast cells (Kumar & Sharma, 2010; Kemp & Lockey, 2002). 
These mediators act on many cellular types, including vascular endothelial cells and 
bronchial smooth muscle, inducing anaphylactic manifestations such as hypotension and 
dyspnea (Winbery & Lieberman, 2002).  
2.3.2 Basophils 
Similarly to mast cells, basophils were identified as cells that present metachromatic granules 
in the cytoplasm. Unlike human, mouse basophils are exceptionally rare (Urbina et al., 1981). 
They are the least common circulating cells that comprise less than 1% of total circulating 
granulocytes and are not normally present in tissues although are recruited to inflammatory 
sites. Basophils may contribute to IgE-mediated allergic inflammation and IgG1-mediated 
systemic anaphylaxis (Mukai et al., 2005; Tsujimura et al, 2008). They arise from bone marrow 
progenitors and complete their terminal differentiation in bone marrow (Arinobu et al., 2005).  
Basophils constitutively express FcRI, high affinity IgE receptor, and upon cross-linking of 
FcRI-bound IgE with specific antigen, they release effector mediators such as histamine, 
leucotrienes, PAF and Th2 cytokines (IL-4, IL-5, IL-13) and TSLP (thymic stromal 
lymphopoietin) in response to protease allergens, causing immediate type hypersensitivity 
(Min, 2008). Mukai et al. (2009) have reported basophils as one of the major players in the 
IgG- but not IgE-mediated systemic anaphylaxis although basophils may function as 
initiator of allergic inflammation. Experiments from Tsujimura et al. (2008) demonstrated 
that mice passively transferred with anti-PenicillinV (PenV) monoclonal IgG1 antibody and 
challenged with PenV-conjugated BSA as allergen presented high drop of body temperature 
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in both mast cell sufficient or deficient mice. They found that mainly basophils captured 
IgG1-immune complexes (they possessed highest amount of allergen per cell in comparison 
with other cell types), the binding was greatly inhibited by treatment with anti-
FcRIIb/FcRIII antibody (against low affinity FcRs), and they secrete high amount of PAF 
when stimulated by IgG1-immune complexes, indicating basophils as a good candidate to 
trigger IgG1-mediated anaphylatic reactions.  
Besides their function as effector cells in IgG1-mediated anaphylaxis, basophils play a crucial 
role as early secretor of IL-4 that is essential to the development of anaphylactic reactions due 
to promoting class-switching to IgE. Sokol et al. (2008) have demonstrated that basophils are 
crucial for the initiation of Th2 cells in response to papain, a cystein protease, which activity is 
commonly found in most allergenic proteins. In addition, other findings reported that naïve 
CD4+ T cells stimulated with peptide-pulsed DCs could develop into Th2 cells when co-
cultured with basophils from wild type mice but not IL-4-deficient mice (Oh et al, 2007), 
enforcing the role of basophils as early source of IL-4 in the immune responses.  
2.3.3 Macrophages 
Macrophages are long lived cells that function as a first line of defense in the body. These 
cells serve as early detector of invading pathogens through PAMPs, as antigen-presenting 
cells which initiate the immune responses, as effector cytotoxic cells to kill directly 
pathogens and also they play a role as regulatory and suppressor cells in parasitic infections 
and tumor-bearing hosts (Gordon, 2003). They arise from monocytes which are released in 
the blood stream and migrate to tissues to differentiate in macrophages or dendritic cells 
according to the stem cell factors milieu (Geissmann et al., 2010). 
Macrophages have been involved in the development of IgG-dependent anaphylactic pathway 
(Oettgen et al., 1994; Miyajima et al., 1997; Strait et al., 2002). Passive immunization with 
allergen-specific monoclonal IgG1 antibody induce systemic anaphylaxis upon allergen 
exposure but this effect can be neutralized by treatment with anti-FcRIIb/FcRIII monoclonal 
antibodies (against low affinity FcRs) and after depletion of macrophages with gadolinium 
(Strait et al, 2002), indicating the participation of macrophages in triggering IgG1-mediated 
anaphylactic reactions. Although platelets and neutrophils have been implicated in IgG-
dependent anaphylaxis (Pinckard et al., 1977; Kimura et al., 1997), Strait et al. (2002) found in 
their studies that the techniques used for platelets and neutrophil depletion may inhibit IgE-
independent anaphylaxis by producing immune complexes that desensitize macrophages, 
mimicking these cells as contributors of FcRIII-dependent anaphylaxis.  
Macrophages along with basophils also contribute to IgG-mediated anaphylaxis by releasing 
PAF upon antigen exposure. It has been demonstrated that the injection of anti-
FcRIIb/FcRIII stimulates macrophages to release PAF by cross-linking FcRIII on these cells 
and also inhibits IgG-dependent anaphylactic responses to antigen by blocking IgG-immune 
complex activation of macrophages through FcRIII (Ujike et al., 1999; Strait et al., 2002). 
2.4 Mediators involved in classical and alternative anaphylactic reactions 
2.4.1 IgE and FcRI 
Ishizaka & Ishizaka (1976) discovered a new class of antibodies capable of transferring 
sensitivity to allergens. IgE antibodies are considered major players in allergic disorders 
such as anaphylaxis, asthma, atopic dermatitis, food allergy (Oettgen & Geha, 1999). It is 
considered the only antibody involved in classical anaphylactic reactions. It is also 
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associated with protective immunity to parasitic infections (Capron et al., 1982). IgE consists 
of two identical heavy chains and two light chains with variable (V) and constant (C) 
regions and no hinge region which makes IgE to be less flexible. The -heavy chains contain 
one variable heavy chain and four constant region domains (C1-4) (Williams & Barclay, 
1988) and are highly glycosylated (Arnold et al., 2007). IgE is the less abundant antibody 
class in serum with normal concentration of 50-200 ng/mL in nonallergic individuals 
(Gould et al., 2003). Even during helminth infections or allergic reactions, human serum IgE 
levels are lower than serum IgG levels; IgG peaks at around 30 µg/mL whereas IgG4 peaks 
at around 680 µg/mL (Bell, 1996). IgE has the shortest half-life of all immunoglobulins. Its 
half-life is about 3 days in serum (Iio et al., 1987), 16 hours on cells in suspension (Ishizaka & 
Ishizaka, 1971) and 2 weeks in tissues when is receptor-bound on cell surfaces (Geha et al., 
1985). Its production requires class-switching from IgM, often via IgG to IgE by somatic 
recombination of germline genes in B cells“, which depends on Th2 cytokines (IL-4/IL-13) 
and CD40 ligation (Poulsen & Hummelshoj, 2007). 
It has been identified three IgE receptors in human (FcRI(2 and 2), galectin-3 and 
FcRII) and four receptors in mice (FcRI(2 and 2), galectin-3, FcRII and FcRIV). 
Most of IgE bind to high affinity IgE receptor (FcRI) that is present in mast cells, basophils 
(Gould et al., 2003) and antigen-presenting cells e.g. Langerhans cells (Bieber et al., 1992). 
FcRI has a central role in mediating the allergic disorders (Kinet, 1999). Cross-linking of 
FcRI associated to IgE with specific antigens induces the release of preformed mediators, 
newly formed lipid mediators and de novo synthesis of cytokines that potentially mediate 
anaphylactic reactions or prolonged allergic inflammation. FcRI shares a common 
oligomeric structure, comprising a ligand binding immunoglobulin-like -subunit 
associated to a -subunit and two -subunits (Daeron, 1997). It binds stably monomeric IgE 
on mast cell surface (Kd  10-10 M). The extracellular domain of -subunit is glycosilated 
which seem to be crucial to appropriate maturation during FcεRI traffic through 
endoplasmic reticulum (Fiebiger et al., 2005) although is not required for monomeric IgE 
binding (Garman et al., 1999). The β- and -subunits bear ITAM (immunoreceptor tyrosine-
based activation motif) that is phosphorylated in tyrosine residues by Lyn after cross-linking 
of FcεRI (Honda et al., 2000). The β-subunit possesses four transmembrane domains and the 
C-terminal domain has an ITAM motif. The -subunit belongs to T cell receptor (TCR) ( gene 
family and is associated to Fc receptors including FcRI, FcRIIA, FcRI (Takai, 2005). Other 
variant of FcεRI is constituted only by three chains (one -subunit and two -subunits) that 
are expressed in monocytes, macrophages and neutrophils (Gould & Sutton, 2008). The low 
affinity IgE receptor (FcεRII) or CD23 is expressed in several cell types including B cells, 
activated T cells, monocytes, eosinophils, platelets, follicular dendritic cells, and thymic 
epithelial cells. CD23 facilitates the antigen presentation to T cells upon binding to IgE-
antigen complex and also plays a role as negative regulator of IgE production (Gould & 
Sutton, 2008). Another IgE receptor is galectin-3 or ε-binding protein, which has been 
reported to be involved in neutrophil activation (Truong et al., 1993). In mice, it has been 
found a fourth type of IgE receptor, FcRIV, which binds IgE-immune complexes on 
macrophage surface, inducing lung inflammation (Mancardi et al., 2008).  
2.4.2 IgG and FcRIII 
IgG antibodies were identified by Tiselius and Kabat in 1939. They immunized rabbits with 
ovalbumin and fractionated the immune serum by electrophoresis into albumin, -globulin, 
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β-globulin and -globluin fractions. The fact that this rabbit serum binds to ovalbumin -
globulin fraction named the immune factor present in rabbit sera as immunoglobulin(Ig) or 
IgG (Tiselius & Kabat, 1939). Classically, there are four types of IgG subclasses in humans 
(IgG1-IgG4) and mice (IgG1, IgG2a, IgG2b, and IgG3). They are the most predominant 
antibody isotype (70-75% of total IgG) in the blood and extravascular compartiments. Four 
different types of FcRs have been identified in mice (FcRI, FcRIIb, FcRIII, and FcRIV). 
The human and primates FcRs have several allelic variants that codify six types of FcRs: 
FcRI, FcRIIa, FcRIIc, FcRIIb, FcRIIIa, FcIIIb.  
Traditionally, these receptors belong to two different categories – they are classified in high 
or low affinity FcRs according IgG affinity to them, and in activating or inhibitory FcRs if 
the type of signaling pathway is triggered by ITAMs (immunoreceptor tyrosine-based 
activation motif) or ITIMs (immunoreceptor tyrosine-based inhibitory motif). Then, FcRI is 
high affinity, activating FcRs in both mice and humans; FcRIII and FcRIV (in mice) and 
FcRIIa, FcRIIc, FcRIIIa, FcRIIIb (in human) are categorized as low affinity, activating 
FcRs; and FcRIIb is the only low affinity, inhibitory FcR in mice and humans. IgGs 
antibodies bind with different affinity and specificity to different FcRs (Dijstelbloem et al., 
2001). In general terms, monomeric IgG binds predominantly to high affinity FcRs (FcRI) 
and IgG-immune complexes binds to low affinity FcR. These receptors are widely 
expressed in haematopoietic cells (except T cells), endothelial cells, osteoclasts, and 
mesangial cells. In mice, monocytes and macrophages express all activating and inhibitory 
FcRs (FcRI-IV), neutrophils express mainly FcRIII, FcRIV and FcRIIb, dendritic cells 
express FcRI, FcRIII, FcRIIb, NK cells only express FcRIII and B cells only have FcRIIb 
(Nimmerjhan & Ravetch, 2008).  
IgG antibodies and FcRIII have been implicated in triggering alternative anaphylaxis 
pathway. Mice lacking mast cells, IgE or FcεRI alpha chain still develop systemic 
anaphylactic responses upon antigen exposure (Jacoby et al., 1984; Oettgen et al., 1994; 
Dombrowicz et al., 1997) whereas FcR deficient mice that lack the expression of Fc(RI and 
activating Fc ( receptors FcRI, FcRIII, FcRIV) have no apparent signal of systemic 
anaphylaxis (Miyajima et al., 1997). Furthermore, it has been found that mice passively 
transferred with allergen-specific monoclonal IgG, particularly monoclonal IgG1, developed 
systemic anaphylaxis upon allergen exposure; when these mice were pre-treated with anti-
FcRIIb/FcRIII, FcRIV monoclonal antibodies, the systemic anaphylaxis was inhibited, 
indicating the role of FcRIII in IgG-mediated anaphylaxis (Strait et al., 2002).  
2.4.3 Histamine and H1 receptor 
Histamine is an autacoid, also referred as 2-(1H-imidazol-4-yl)ethanamine, that modulates 
the cellular function in several tissues including dermis, small intestine, stomach, lungs and 
brain (Jones & Kearns, 2011). Its synthesis depends on histidine decarboxylase (HDC) that 
removes of carboxylic acid residue on the histidine side chain in the Golgi apparatus. It is 
stored basically in mast cells and basophils although it has been demonstrated that other cell 
types (e.g. neutrophils, lymphocytes, monocytes, dendritic cells, platelets, gastric cells and 
brain histaminergic cells) express HDC (MacGlashan, 2003). The release of histamine occurs 
in response to cross-link of antigen-specific IgE on mast cells and basophils surfaces upon 
antigen exposure during systemic anaphylaxis and the early phase of allergic responses. 
Large quantities of histamine (10-5 to 10-3 mol/L) are released within 30 minutes after 
allergen exposure (Simons, 2003). Histamine and other released mediators such as 
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leukotrienes and prostaglandins produce the acute symptoms including pruritus of nasal 
mucosa, eyes, skin and increased vascular permeability, vasodilatation and edema resulting 
in nasal congestion, rhinorrea and conjuntival edema and erythema (Clough et al., 1998). 
Histamine can cause bronchoconstriction due to mucus accumulation by activated globet 
cells in the lung (Golightly & Greos, 2005) and may be involved in airway remodeling 
(Kunzmann et al, 2007). Histamine is responsible for mast cell activation by stimulating the 
secretion of cytokines and chemokines from T and B lymphocytes which up-regulates 
adhesion molecules in epithelial cells (Akdis & Blaser, 2003). 
Histamine binds to four major receptors (H1, H2, H3 and H4) which belong to G-protein 
seven transmembrane receptor family. H1 receptor has been widely discussed in 
anaphylactic disorders. Histamine binds to H1R that activates inositol-1, 4, 5 pathway, 
mobilizing intracellular calcium which induces the vascular endothelium to release nitric 
oxide and stimulate guanyl cyclase to increase the production of cyclic GMP in vascular 
endothelial cells. This cascade promotes vasodilatation, erythema, vascular permeability 
and edema (Li et al, 2003). Activation of H1R produces direct effect in bronchial smooth 
muscle leading to bronchoconstriction. H1 and H2 receptors are overexpressed in patients 
with asthma in contrast to patients with rhinitis only (Botturi et al, 2010). The H2 receptor is 
expressed on gastric mucosa, vascular smooth muscle, brain, adipocytes and immune cells. 
Activation of H2 results in relaxation of smooth muscle in the airway and vasculature 
(Akdis & Simons, 2006). The stimulation of H3 receptor is been involved in pruritus 
(Sugimoto et al, 2004) and H4 receptor may play a role in inflammatory processes by 
inducing chemotaxis and calcium influx in bone marrow-derived and tracheal mast cells 
migration from connective tissue toward epithelium (Thurmond et al, 2004).  
2.4.4 Platelet activation factor (PAF) 
The term PAF was first used to describe the factors that aggregate and activate platelets 
(Benveniste et al., 1972). PAF is a potent proinflammatory phospholipid synthesized from the 
cleavage of glycerophospholipids by phospholipase A2 that binds to PAF receptor, a G-protein 
coupled seven-transmembrane receptor. It is active at concentration as low as 10-12M (Stafforini 
et al, 2003). Since its discovery, pleiotropic effects of PAF have been demonstrated, including 
its role in bronchoconstriction, hypotension, vascular permeability, chemotaxis, degranulation 
of eosinophils and neutrophils (Hanahan, 1986). PAF is released from mast cells, basophils and 
macrophages upon antigen stimulation in human and experimental anaphylactic reactions 
(Vadas et al., 2008; Finkelman, 2007). Histamine, which can be secreted by mast cells and 
basophils, effectors cells in classical anaphylactic pathway, is a potent agonist for PAF 
synthesis by human endothelial cells (McIntyre et al., 1985). Circulating levels of PAF are 
controlled by the activity of PAF acetylhydrolase, enzyme that rapidly degrades PAF, making 
its half-life very short; it ranges from 3 to 13 minutes (Karasawa, 2006).  
Vadas et al. (2008) have found that PAF levels positively correlate with the severity of 
anaphylaxis and may be pivotal for anaphylaxis outcome. Serum PAF levels is significantly 
elevated in allergic patients with severe anaphylaxis than those with milder manifestations 
of anaphylaxis. PAF has been identified as relevant vascular leak mediator in anaphylaxis 
(Camerer et al., 2009). The deletion of PAF receptor impairs anaphylactic responses in 
genetically manipulated mice (Ishii et al., 1998). In addition, recombinant PAF 
acetylhydrolase is protective and reduces mortality in experimental models of anaphylaxis 
(Fukuda et al., 2000; Gomes et al., 2006). Furthermore, PAF stimulate NO (nitric oxide) 
production by enhancing the activity of NOS (constitutive nitric oxide synthase), instead of 
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iNOS (inducible nitric oxide synthase), which relaxes vascular smooth muscle, leading to 
hypotension and death (Cauwels et al., 2006). 
2.4.5 IL-4 and IL-4Ralpha 
IL-4 is a pleiotropic type I cytokine, recognized as signature cytokine of Th2 immune 
responses (Swain et al., 1990). It is produced by Th2 CD4+ T cells, basophils, mast cells, 
eosinophils and CD1-restricted NKT cells upon stimulation (Paul, 1997). IL-4 binds to IL-4 
receptor, which is a heterodimer of IL-4 receptor  chain and common  chain, resulting in 
phosphorylation of STAT6 (signal transducer and activator of transcription 6) (Nelms et al., 
1999).  
IL-4 exacerbates anaphylaxis through a direct effect on mast cell and basophils or through 
enhancing antibody production. Strait et al. (2003) have demonstrated that IL-4R signaling 
increase the responsiveness of mast cell- and macrophage-secreted mediators such as 
histamine, PAF, serotonin and leukotriene C4. IL-4 increases anaphylactic responses in a 
mouse model infected with Thrichinella spiralis by increasing histamine and PAF, but also 
enhances anaphylaxis at doses lower than those produced by helminth infections (Conrad et 
al., 1990). The contribution of IL-4/IL-4R in the anaphylaxis is also associated to their role 
in antibody production. IL-4 promotes class-switching to IgE antibodies (Finkelman et al., 
1988) but it does not seem crucial to IgG1 production since high IgG1 levels is found in mice 
treated with anti-IL-4, and in IL-4 or STAT-6 deficient mice (Finkelman et al., 1989; Kuhn et 
al., 1991; Shimoda et al., 1996).  
3. Helminth infections as predisposed factors to allergic and anaphylactic 
reactions 
Helminths are known to cause widespread infections, mainly in tropical and subtropical 
areas in the developing world where the water suply and sanitation conditions are not 
adequate (De Silva et al., 2003). Although they did not cause high mortality, they tend to 
cause chronic infections in populations that live in endemic area, leading to iron-deficiency 
anemia and malnourishment and interfering with physical and mental growth in children 
(Stephenson et al., 2000).  
The immune response against helminth infections is associated with high production of IgE 
levels and tissue infiltration of eosinophils, mast cells and Th2 cells which secrete IL-4, -5 
and -13 (Fallon & Mangan, 2007). Th2 immune responses are believed to mediate protective 
immunity against these parasites (Anthony et al., 2007). Certain parasites such as Schistosome 
mansoni produce a strong Th2 immune response that is correlated with the formation of Th2 
granuloma around schistosoma eggs (Wilson et al., 2007). 
Several studies have demonstrated that helminth infection may increase allergic 
inflammation. Individuals exposed to helminthes for a short time often have allergic-like 
manifestations (Cooper, 2009). Lynch and collaborators (Lynch et al., 1984, 1987, 1992, 1997) 
have shown that the intensity of helminth transmission determines the effect of helminth 
infection on allergic reactivity - in high income urban areas where the transmission is low, 
the allergic reactivity is high whereas in urban and rural areas where people are chronically 
infected by helminthes, the allergic reactivity is low. Geohelminth parasite with pulmonary 
larval stages, such as Ascaris lumbricoides, Necator americanus, Ancylostoma duodenale and 
Strongyloides stercoralis, are found to cause Loeffler’s syndrome which is characterized by 
eosinophilic infiltrate into the lungs after parasitic infection (Loefller, 1959).  
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Corroborating with Lynch’s studies, it has been reported high association between dust 
mites and parasitic diseases in tropical allergies (Caraballo & Acevedo, 2011). Mites are 
important source of allergens in tropical areas (Fernandez-Caldas et al., 1993, 2008). The 
warm temperatures and high humidity facilitate the proliferation of dust mites such as 
Blomia tropicalis and Dermatophagoides pteronyssinus (Puerta et al., 1993). Likewise, nematodes 
are highly prevalent in tropical areas. Ascaris lumbricoides is the most prevalent, affecting 
around 1.5 million people worldwide (McSharry et al., 1999) by oral contamination with 
embryonated eggs that differentiate in migratory larvae, compromising intestine, liver, and 
lungs (Bradley & Jackson, 2004). Cross-reactivity between mites and Ascaris could explain 
why there is a positive correlation between allergies caused by dust mites and nematode 
infections in tropical areas. Acevedo et al. (2009) found cross-reactivity of specific IgE and 
tropomyosin from B. tropicalis, D. pteronyssinus and A. lumbricoides in asthmatic patients. It is 
postulated that high prevalence of specific IgE to mites in a tropical environment may be 
influenced by cross-reactivity with Ascaris spp. allergens (Acevedo et al., 2011). Another study 
also suggested that nematode infections may induce reactivity to tropomyosin in atopic 
individuals. Santiago et al. (2011) have demonstrated that there is 72% of amino acid identity 
between tropomyosin from D. pteronyssinus (Der p10) and Onchocerca volvulus in sera from O. 
volvulus-infected and non-infected atopic individuals and the prevalence of Der p10-specific 
IgE and IgG was increased in O. volvulus-infected individuals. Besides Ascaris infection, HDM 
(house dust mite) sensitization is strongly associated to wheeze symptoms in individuals from 
urban areas than in rural areas that had Trichuris infection (Scrivener et al., 2001).  
Cooper (2009) and Smits et al. (2010) have listed four factors that may determine the effect of 
helminthic infections in promoting allergic responses (Figure 2): 1) Timing - periodic 
helminth infections in adult age (acute infections) may induce allergic manifestations 
whereas long-lasting helminthic infections in early age (childhood) (chronic infections) may 
suppress allergic inflammation due to inducing an immunomodulatory environment. 2) 
Intensity of infection – light parasite burden may induce allergic manifestations and heavy 
parasite burdens may induce down-modulation of allergic symptoms. 3) Host genetics – 
atopic individuals may be more likely to develop allergic manifestations than non-atopic 
individuals. 4) Parasite – different helminthes have different effects on atopy and allergies, 
parasites with larvae stages in the lung and skin than in other organs/tissues may be more 
predisposed to allergic manifestations. 
4. Helminths and their products as anti-inflammatory modulators for allergic 
and anaphylactic disorders  
Despite inducing strong Th2 and being considered predisposing factor to allergic 
manifestations, helminth infections can induce suppression of allergic diseases. Smits et al. 
(2010) related that chronic helminth infections may protect against allergic diseases by 
stimulating regulatory B and T cells and modulating dendritic cell functions. The 
immunosuppressive effect of helminthes and their products in the immune response have 
been widely reported in the literature (Smits et al., 2010; Hewitson et al., 2009; Soares & 
Araujo, 2008; Harnett & Harnett, 2008; Maizels et al., 2004). Helminth molecules can degrade 
some host molecules such as eotaxin and antibodies, inhibit the formation of reactive 
oxygen and nitrogen intermediates, interfere with macrophage activaction, down-modulate 
the antigen presentation by dendritic cell and macrophages, and mimic cytokines such as 
IFN-, TGF- and MIF. 
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Fig. 2. Helminth paradigm. Helminthes can stimulate allergic manifestations or suppress 
inflammatory/anaphylactic responses depending on time and intensity of the infection, host 
genetic background and parasite life cycle. 
Helminth infections can impair immune response toward heterologous antigen (Stewart et 
al., 1999), allografts (Liwski et al., 2000), viral infections (Actor et al., 1993) and other 
helminth infections (Jenkins, 1975). Helminths employ several immunomodulatory 
strategies in order to evade and/or modify the host immune response and, consequently, 
perpetuate their survival in the host (Playfair, 1982), including inactivation and/or 
modulation of the host protective immune response. The immunomodulation has been 
considered beneficial both to the host and the parasites since it could avoid helminth 
erradication and protect the host from inflammatory responses that may damage the host´s 
tissue (van Riet et al., 2007). 
It has been identified several immunomodulatory molecules and strategies by which the 
helminths evade the host immune system, permitting that the parasites subvert the host 
protective responses. Some of these molecules include eotaxin metalloproteinase (Culley et 
al., 2000), calreticulin (Pritchard et al., 1999), antioxidants (Brophy et al., 1995) and 
neutrophil inhibitory factor (Moyle et al., 1994). They can interfere with antigen processing 
and presentation (Dainichi et al., 2001), cell proliferation (Allen & MacDonalds, 1998), cause 
T cell death (Semnani et al., 2003), decrease IgE responses (Langlet et al., 1984), reduce B cell 
activation (Deehan et al., 1997) and stimulate regulatory T cells (Belkaid et al., 2006). In this 
section, we will discuss about some helminth products and their immunomodulatory effect 
in the immune system (Figure 3). 
Children 
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Fig. 3. Some immunosuppressive products secreted by helminthes that may be used as 
therapeutic strategies for anaphylactic disorders. Helminth can secrete molecules that 
possess down-modulatory effect on the host’s immune system. The upper panel show some 
molecules secreted by helminthes and the lower panel show the cell targets of the helminth-
secreted products. Abs, antibodies; Ag, antigen; ES, excretory/secretory products; MIF, 
macrophage-migration inhibition factor; MDSC, myeloid-derived suppressor cells; NO, 
nitric oxide; iNOS, inducible nitric oxide synthase; PAF, platelets-activating factor; PAS-1, 
protein from Ascaris suum; Treg, regulatory T cells. 
4.1 Helminth products and their strategies to immunomodulate the host immune 
responses 
4.1.1 Cleavage of host immune system molecules  
It has been described several helminth defense mechanisms that can block host immune 
system by cleaving immune factors. The adult stage of Nippostrongylus brasiliensis releases in 
in vitro culture a product with acetylhydrolase activity that promotes cleavage of platelet-
activating factor (PAF), promoting bronchoconstriction and increasing vascular 
permeability (Blackburn & Selkirk, 1992). Excretory/secretory (ES) products from 
hookworm Necator americanus cleave eotaxin (Culley et al., 2000), and in this way inhibit the 
recruitment of eosinophils, pivotal cells in development of the late phase of allergic 
responses. 
Helminth serpins can also interfere in the immune response by cleaving immune factors. 
Serpins are an extensive family of serine proteinase inhibitors which regulate a wide variety 
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of proteinase-dependent physiological functions, such as blood coagulation, fibrinolysis, 
activation of complement, and the inflammatory response (Potempa et al., 1994). A serpin 
produced by microfilarial stage of Brugia malayi, Bm-SPN-2, inhibits the enzymatic activity 
of serine proteinases, cathepsin G and elastase from human neutrophils (Zang et al., 1999). 
In addition, Smpi56, a serpin from Schistosoma mansoni, inhibits the neutrophil elastase 
(Ghendler et al., 1994), protecting the parasite from activated neutrophils during 
inflammation. 
Besides promoting the cleavage of PAF, eotaxin and inactivation of neutrophil enzymes, 
helminth products also can cleave host antibody. Antibody cleavage is critical for the 
parasite evasion because it inhibits ADCC (antibody-dependent cell cytotoxity) and 
promotes IgG degradation, which blocks FcR-mediated cytokine release. For instance, ES 
products from Fasciola hepatica cleave all human IgG subclasses at the hinge region (Berasain 
et al., 2000). In addition, S. mansoni schitosomula produces a trypsine-like proteinase or 
aminopeptidase that cleave Fab fragment when Fc receptor of the worm binds IgG (Auriault 
et al., 1981). Recombinant schistosome aspartic proteases from S. japonicum cleave 
specifically human IgG, suggesting that these proteases may play a role in the degradation 
of host serum proteins ingested as part of the schistosome bloodmeal (Verity et al., 2001). 
4.1.2 Modulation of nitric oxide production  
Nitric oxide (NO) is a potent microbicidal agent that plays a role in host defense against 
parasites. This effect has been demonstrated toward several helminthes. It has been found 
that ES products from parasites such as Spirometra erinacei (Fukumoto et al., 1997), Anisakis 
simplex (Cuellar et al., 1998), Heligmosomoides polygyrus (Rzepecka et al., 2006) suppress the 
expression of iNOS in LPS-activated macrophages in a dose dependent manner. However, 
filarial nematode cystatins (Hartmann et al., 2002) up-regulate NO production from IFN--
activacted macrophages. In spite of the susceptibility of parasites to NO, its stimulation in 
the host by helminth products is critical to promote nitration and oxidation of host´s 
molecules and damage several biological processes. Moreover, in filariasis murine model 
NO production was associated with suppression of T cell proliferation (O’Connor et al., 
2000), suggesting that the secretion of NO is linked to microfilariae killing and T cell 
response inhibition. 
4.1.3 Interference with antigen presentation and T cell responses 
Helminth cystatins are thought to be the most important molecules that interfere with 
antigen presentation. Cystatins constitute a family of cysteine protease inhibitors that are 
widely distributed and play essential roles in a spectrum of physiological processes (Barrett, 
1986). Nematode cystatins could lead to severe changes in antigen processing and inhibit 
efficient generation of peptide-MHC class II molecule, decreasing the antigen presentation 
by APC. These molecules target cysteine proteases such as cathepsins, which play a role in 
two catalytic processes (Hartmann & Lucius, 2003). First, cysteine proteases degrade 
proteins within the endosomal-lysosomal compartment of APC. Second, cysteine proteases 
are involved in the cleavage of the MHC class II-associated invariant chain, which leads to 
the formation of MHC molecules associated to CLIP (class II-associated invariant chain 
peptide). Then, synthesized CLIP molecules allow the binding of peptides to MHC class II 
molecules to promote antigen presentation. The invariant chain cleavage is promoted by 
cathepsins S in B cells and dendritic cells (Riese et al., 1996), cathepsins L in thymus 
epithelial cells (Nakagawa et al., 1998) and cathepsin F in macrophages (Shi et al., 2000).  
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Nematode cystatins are homologous to mamalian cystatin C, which are highly expressed by 
immature dendritic cells and are down-regulated during dendritic cells maturation process 
to permit the transport of MHC II molecules to cell surface. Parasite cystatins maintain 
dendritic cells in immature state, preventing the antigen presentation by these cells and also 
down-regulate in vitro cellular proliferation (Pierre & Mellman, 1998). The first described 
parasite cystatin was onchocystatin, derived from Onchocerca volvulus (Lustigman et al., 
1992), that down-regulates the HLA-DR expression by human monocytes after 72 hours of 
co-culture (Hartman et al., 1997). Brugia malayi nematodes secrete two homologues cystatins 
(Schonemeyer et al., 2001; Manoury et al., 2001): Bm-CPI-1, which is selectively expressed by 
L2 and L3 stage into the mosquito vector and Bm-CPI-2, which is constitutively expressed 
during the parasite life and interferes with two classes of proteases in the MHC class II 
antigen presentation: cathepsins B, L and S and asparagine endopeptidase. Also, Bm-CPI-2 
blocks the presentation of peptide derived from tetanus toxoid by human B cells. 
Nippocystatin, a cysteine protease inhibitor found in ES products from N. brasiliensis, 
modulate the antigen processing and interfere with antigen presentation due to inhibiting 
multiple cysteine protease activities found in endosomes/lysosomes of B cells (Dainichi et 
al., 2001). In addition, Litomosoides sigmodontis cystatins upregulate the production of tumor 
necrosis factor alpha (TNF-) and decrease antigen-specific proliferation of spleen cells in 
mice (Pfaff et al., 2002). Besides inhibiting proteases from MHC classe II pathway, cystatins 
can also down-modulate T cell proliferation and up-regulate IL-10 production (Hartmann et 
al., 1997; Schonemeyer et al., 2001). ES62, a phosphorylcholine-bearing filarial product, 
secreted by Acanthocheilonema viteae, desensitizes LPS-stimulated mouse peritoneal 
macrophages to produce IFN- (Goodridge et al., 2001). ES-62 also reduces lymphocyte 
proliferation and stimulates anti-inflammatory properties (Harnett & Harnett, 2001). 
Phosphorylcholine(PC)-containing glycosphingolipids from Ascaris suum are 
immunomodulatory molecules due to the fact that they inhibit BCR-mediated B cell 
proliferation by causing apoptosis, inhibit LPS-induced activation of B cells by decreasing 
Erk phosphorylation, modulate IL-12p40 production in LPS/IFN--induced peritoneal 
macrophages (Deehan et al., 2002) indicating the PC moiety is important to induce the 
immunomodulatory effect. In addition, lysophosphatidylserine from S. mansoni can 
specifically target the immune system via TLR-2, interacts to dendritic cells and induce IL-
10-producing regulatory T cells involved in immunosuppression (van der Kleij et al., 2002).  
4.1.4 Stimulation of myeloid-derived suppressor cells 
Several carbohydrate components derived from helminthes also modulate the immune 
response by stimulating myeloid-derived suppressor cells (MDSC) (Reyes & Terazas, 2007) 
These cells are a heterogeneous population of cells that express CD11b and Gr-1 and 
consists of early myeloid progenitors and immature myeloid cells (macrophages, 
granulocytes and dendritic cells) at different stages of differentitation (Gabrilovich & 
Nagaraj, 2009). The basic concept about suppressor cells is based on the findings of 
Gordon’s group who observed a direct in vitro effect of IL-4 on the expression of mannose 
receptor in macrophages (reviewed in Gordon, 2003). This observations lead to 
macrophages being categorized in classically-activated (CA) macrophages which are NO- 
and IFN--dependent (Kusmartsev et al., 2000) and alternatively-activated (AA) 
macrophages which are IL-4- or IL-13-dependent (Kreider et al., 2007; Goerdt et al., 1999). In 
this regard, Mantovani et al. (2004) proposed that macrophages can be polarized in 
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inflammatory (M1) or anti-inflammatory (M2) conditions. Besides, M2 macrophages can be 
classified into subpopulations M2a (which are AA macrophages) and M2b (which are IL-10-
secreting cells upon immune complex activation), and M3c (which are IL-10-induced 
deactivated macrophages). All these type of macrophages (and other suppressor cells) can 
be found in several different of immunological situations, including tumors, autoimmunity, 
intracellular pathogen infections, helminthic infections.  
Two glycans derived from Schistosoma eggs, lacto-N-fucopentaose III and lacto-N-
neotetraose, have been related to induce IL-10 production, suppressing T cell proliferation 
(Terrazas et al., 2001). Soluble egg antigens (SEA) from S. mansoni, which are rich in lacto-N-
fucopentaose III, suppress the LPS-induced inflammation by inducing Th2 responses 
(Pearce & MacDonald, 2002), by enhancing production of IL-10 and impairing dendritic cell 
(DC) activation. This latter property is due to the fact that SEA inhibit MyD88-independent, 
but not dependent-, pathways which result in IL-10 production (Kane et al., 2004), 
suggesting that SEA regulate multiple signaling pathways downstream and may target the 
initiation signaling in DC. The suppression of DC activation could be through the ligation of 
mannose receptor or DC-SIGN (DC-specific intercellular adhesion molecule-grabbing non-
integrin) that results in inhibition of DC to secrete IL-12 in response to TLR ligands (Nigou 
et al., 2001). DC-SIGN ligation leads to IL-10 production, which has been implicated in 
suppression of DC function (Geijtenbeek et al., 2001). It has been found that lacto-N-
fucopentaose III presents an anti-inflammatory effect due to inducing Th2 response and 
functioning as an adjuvant (Okano et al., 2001). High levels of IL-4, IL-5, IL-10, but not IFN-
, are secreted by nasal lymphocytes from mouse immunized with human serum albumin 
conjugated to lacto-N-fucopentaose III. Lacto-N-fucopentaose III is also able to expand 
peritoneal macrophages that bear Gr1+ marker and act as suppressor cells, inhibiting CD4+ 
T cell proliferation via NO- and IFN--dependent mechanisms (Atochina et al., 2001).  
Carbohydrate components from Taenia crassiceps also favor Th2 responses, stimulating IgG1 
and polyclonal IgE responses, IL-4, IL-5, IL-10 production to a bystander antigen and are 
critical to induce gene expression in AA macrophages (Gomes-Garcia et al., 2006), indicating 
that these components enhance Th2 responses as an adjuvant and trigger anti-inflammatory 
responses by stimulating AA macrophages. Glycans from Taenia crassiceps in their 
conformational structure recruit F4/80+ Gr1+ peritoneal exudate cells and suppresses 
proliferation of CD90+ cells (T cells) via cell-to-cell contact, not via IFN- and NO (Gomes-
Garcia et al., 2005). Moreover, T. crassiceps glycans did not activate F4/80+ Gr1+ cells (M2a 
macrophages) through TLR-4 as has been proposed to synthetic and natural glycoconjugates 
(Terrazas et al., 2001; Atochina et al., 2001). In addition, the treatment of intact glycans with 
sodium periodate, which removes glycosilation, decrease M2a macrophages indicating that 
intact glycans are essential to recruit F4/80+ Gr1+ cells. 
4.1.5 Inititation of Th2 immune responses 
S. mansoni eggs secrete two proteins that have been implicated in Th2 differentiation: alpha-
1 and omega-1. Alpha-1 is a dimer that cross-link IgE-FcRI complex on basophils, in an 
antigen-dependent manner, hence being named IL-4 inducing principle of schistosoma eggs 
(IPSE). It induces the degranulation of mouse and human basophils and releases of IL-4 
release (Schramm et al., 2003, 2007), initiating Th2 differentiation. Omega-1 is a ribonuclease 
also secreted by schistosoma eggs which is necessary to egg transit into the host tissues 
(Fitzsimmons et al., 2005). It is believed to be involved in Th2 responses by conditioning 
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human monocyte-derived dendritic cells to drive Th2 polarization (Everts et al., 2009; 
Steinfelder et al., 2009).  
4.1.6 Mimicry of cytokines and other mediators 
Helminthes can produce homologous proteins to immune system mediators/receptors, such 
as TGF-, IFN-, TNF-R and histamine that play a role in regulating anti-parasite 
responses. Parasite-encoded TGF- molecules have been characterized in filarial nematodes 
Brugia malayi and B. pahrangi. They are two TGF- homologues that show to be differentially 
regulated during the filarial life cycle: tgh-1 in Brugia malayi and B. pahangi (Gomez-Escobar 
et al., 1997), and tgh-2 in B. malayi (Gomes-Escobar et al., 2000). Tgh-1 molecule is required 
for filarial development within the human host (Gomes-Escobar et al., 1998) and Tgh-2 is 
predominantly expressed in adult stages and binds to the human TGF- receptor (Hirata et 
al., 2005), mimicking human TGF- and stimulating regulatory responses in the host. In 
addition to Brugia species, TGF- immunorective molecules have been detected at the 
surface of cervical bodies, in tegument and subtegumental cells of other parasite stages of 
Schistosoma japonicum, during the whole life cycle (eggs, cercariae, schistosomula and adult 
worms), although being distinctly regulated at each developmental stage (Davies et al., 
1998). 
Besides TGF- homologues, TGF- receptor homologues have also been described in Brugia 
and Schistosoma species. SmTR1 or SmRK1, a homologue of type I TGF- receptor and a 
type of TGF- family of receptor serine/threonine kinase, have been shown in Schistosoma 
mansoni surface following its entry into the mammalian host (Forrester et al., 2004). In 
addition to expressing SmRK1, S. mansoni expresses another type I TGF- receptor, SmRK2, 
from schistosomula and adult stages and it is located predominantly to the tegumental 
surface of parasite (Grencis & Entwistle, 1997). Type I TGF- receptor (Bp-trk-1) has been 
also isolated from the filarial parasitic nematode Brugia pahangi in the three main stages of 
its life cycle: microfilariae, infective larvae and adults; although the ligand remains 
unknown, it may likely act as a receptor for host TGF- rather than for parasite ligands 
(Gomes-Escobar et al., 2000). 
Helminths also produce homologues that mimic IFN-. Trichuris muris-derived molecules 
share cross reactive epitopes with the host IFN-. Moreover, these molecules can be shown 
to bind to IFN- receptor and induce change in lymphoid cells similar to those induced by 
murine IFN- (Calandra & Bucala, 1997). Thus, it possible that the host immune system 
produces IL-4 to expulse the worms, the IFN- homologue production may perpetuate the 
parasite survival into the host.  
Other types of molecules that mimic the host cytokines are macrophage-migration inhibition 
factors (MIFs), which are produced by several nematodes. Mammalian MIFs are small 
proteins produced by non-haematopoietic cells that act as pro-inflammatory cytokines and 
induce TNF production by macrophages in acute settings, such as septic shock (Pastrana et 
al, 1998). The first MIF homologue to be characterized from a nematode was BM-MIF-1 
identified in the filarial parasite Brugia malayi, but Wuchereria bancrofti and O. volvulus also 
encode MIF family proteins (Reyes & Terrazas, 2007). It may play multiple roles in host-
parasite interaction due being located in several tissue types and being found in both cell-
associated and secreted forms. Possibly, helminthes may secrete MIF molecules down-
modulate the inflammatory response, mainly by stimulating myeloid-derived suppressor 
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cells that has been found to play down-regulatory functions in helminth infections, such as 
T cell proliferation inhibition and IL-10 and TGF- release. 
5. PAS-1, an anti-inflammatory protein from Ascaris suum 
Our research group has been investigating the effect of Ascaris suum infection and secreted 
products in the inflammatory response. We have been demonstrated that components from 
Ascaris suum body extract modulate the antibody response and the cell-mediated response 
in mice. Soares et al. (1987) have demonstrated that, besides inhibiting the IgE production, 
A. suum extract suppresses the IgG1 and IgG2a antibody production. Ferreira et al. (1995) 
have shown that DBA/2 mice immunized subcutaneouly with OVA + A. suum extract and 
challenged with OVA in the footpad present suppression of immediate (3 hour after 
challenge) and late (24 hours after challenge) type IV hypersensitivity reaction. The isolation 
of protein fractions from A. suum extract by Sephacryl S-300 gel filtration chromatography 
yields three peaks (PI, PII, and PIII). PI is constituted by high weight components that 
suppress anti-OVA IgE antibody production in mice immunized with OVA + PI (Soares et 
al., 1992; Faquim-Mauro & Macedo, 1998). Thus, the suppressive effect observed in A. suum 
extract is due to high molecular weight components. PI protein fraction was used to obtain 
the monoclonal antibody MAIP-1, which recognizes one of the suppressive components in 
the A. suum extract; it is a 200-kDa-protein named PAS-1 (protein from Ascaris suum) (Oshiro 
et al., 2004). 
PAS-1 suppresses the LPS-induced leukocyte migration and pro-inflammatory (IL-1, IL-6 
and TNF-) cytokines production in air pouches exudates and macrophage culture 
supernatant; moreover, it stimulates the production of IL-10 and TGF- (Oshiro et al., 2005), 
indicating that the modulatory effect of PAS-1 in LPS-induced inflammation is likely due to 
these two cytokine. Furthermore, PAS-1 was demonstrated modulating the humoral and 
cellular immune response against OVA. It inhibits the production of IgM, IgG1, IgG2a, IgE 
and anaphylactic IgG1 toward T-dependent but not T-independent, antigens and anti-OVA 
type IV hypersensitivity reaction in mouse footpad injected with carrageenan (Oshiro et al., 
2006), suggesting that PAS-1 suppresses B and T cell responses. 
PAS-1 also down-modulates antibody production, Th2 cytokine secretion, cellular 
recruitment and airway hyperesponsiveness induced by APAS-3, allergenic protein from A. 
suum (Itami et al., 2005). We have demonstrated that regulatory T CD4+CD25+ cells and T 
CD8+ cells secrete IL-10/TGF- and IFN-, respectively and they are involved in the 
mechanisms by which PAS-1 down-modulate the acute lung allergic inflammation in mice 
since OVA-induced inflammation is reverted when PAS-1-primed regulatory T CD4+CD25+ 
cells or T CD8+ cells are adoptively transferred to OVA-immunized mice (Araujo et al., 
2008; De Araujo et al., 2010). Besides playing an immunosuppressive role in the acute lung 
inflammation, we recently found that PAS-1 decreases the airway remodeling and 
angiogenesis in a mouse chronic lung inflammation model induced by OVA or APAS-3 by 
inhibiting metaloproteinases (MMP-2, MMP-9, ADAM-33) and angiogenic factors (VEGF 
and IL-13) (Araujo et al., manuscript in preparation). 
6. Conclusion 
In conclusion, anaphylaxis is a life-threatening and systemic disorder that involves two 
different pathways: classical anaphylactic pathway which is IgE-dependent mechanism 
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triggered by IgE-FcRI signaling on mast cell and basophils to secrete histamine, and 
alternative anaphylactic pathway which is IgG-dependent triggered by IgG-immune 
complex bound to FcRIII on basophils and macrophages to secrete PAF. The understanding 
of molecular and cellular mechanisms involved in the anaphylactic disorders is crucial to 
investigate terapeuthic strategies for preventing anaphylaxis risk and recurrence. 
Helminths secrete several immmunomodulatory factors that can modulate inflammatory 
response. Some helminth products can cleave host molecules, such as chemokines, 
antibodies, and enzymes; modulate the NO production; interfere with antigen presentation 
and T cell responses by down-modulating DC functions; mimic cytokines such as IFN- and 
TGF- and MIF. Other potent immunodulatory molecule from helminth is PAS-1, a protein 
from A. suum, that down-modulate acute inflammatory responses and chronic lung allergic 
inflammation, decreasing IgG1 and IgE production, eosinophil infiltrate, and Th2 cytokines 
and interfering with metaloproteinase activity and production of angiogenic factors. Thus, 
due to their capacity to induce immunomodulation, these helminth products may be useful 
for therapeutic interventions in inflammatory, allergic and anaphylactic disorders.  
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